Alterations in Immune Function
Alterations in Immune Function
Course Overview
Instructor: C Constantin, PhD, RNC
Hypersensitivity Topics
Immune Deficiencies
Primary Immunodeficiencies
Secondary (Acquired) Immunodeficiencies
HIV/AIDS
Countermeasures to Infection
Hypersensitivity
Specific Objectives
Describe and compare the four types of hypersensitivity reactions.
Describe how an individual becomes sensitized to an allergen in type I hypersensitivity reactions.
Hypersensitivity Reactions Definition
Hypersensitivity: An altered immunologic response to an antigen that leads to disease or damage to the host.
Classification methods:
Source of Antigen:
Allergy
Autoimmunity
Alloimmunity* (response to antigens from members of the same species)
Mechanism Causing Disease:
Type I
Type II
Type III
Type IV
Examples of Hypersensitivity and Their Characteristics
Type I:
Mechanism: IgE-mediated reaction.
Rate of Development: Immediate.
Principal Effector Cells: Mast cells.
Antibody Involvement: No.
Disorders: Seasonal allergic rhinitis, latex allergy.
Type II:
Mechanism: Tissue-specific reaction.
Rate of Development: Immediate.
Principal Effector Cells: Macrophages in tissues.
Antibody Involvement: Frequently.
Disorders: Autoimmune thrombocytopenic purpura, Graves' disease.
Type III:
Mechanism: Immune complex-mediated reaction.
Rate of Development: Delayed.
Principal Effector Cells: None.
Antibody Involvement: Yes.
Disorders: Systemic lupus erythematosus.
Type IV:
Mechanism: Cell-mediated reaction.
Rate of Development: Delayed.
Principal Effector Cells: Lymphocytes,
macrophages.
Antibody Involvement: No.
Disorders: Contact sensitivity to poison ivy and metals.
Sensitization in Hypersensitivity Reactions
Sensitization requires exposure to a particular antigen that leads to both primary and secondary immune responses.
The sensitization process can be rapid (after just one exposure) or require several exposures.
Example: Poison Ivy Reaction, PPD skin test.
Timing of Immune Responses
A person is considered sensitized when they possess sufficient antibodies or T cells to cause a measurable reaction upon re-exposure to the antigen.
Hypersensitivity reactions may be:
Immediate: Minutes to a few hours after exposure.
Delayed: Several hours; maximum severity occurs days after re-exposure.
Types of Hypersensitivity Reactions
Type I:
IgE-mediated reactions leading to anaphylaxis or allergic responses.
Examples: Bee stings, drug reactions, asthma, latex allergy.
Type II:
Tissue-specific antibody-mediated reactions causing destruction of target cells.
Conditions: Hemolytic disease of the newborn, autoimmune hemolytic anemia.
Type III:
Immune complexes cause tissue inflammation and damage.
Conditions: Serum sickness, rheumatoid arthritis.
Type IV:
T-cell mediated responses that are delayed.
Conditions: Tuberculosis skin test, poison ivy reactions.
Anaphylaxis
Definition: Most rapid and severe immediate hypersensitivity reaction (Type I).
Timeframe: Occurs within minutes of re-exposure.
Types: Systemic (widespread) and cutaneous (localized).
Symptoms of systemic anaphylaxis may include:
Itching, erythema, headaches, vomiting, abdominal cramps, diarrhea, and breathing difficulties.
Severe cases can involve bronchial smooth muscle contraction, laryngeal edema, and vascular collapse.
Type II Hypersensitivity
Description: Antibody-mediated destruction of target cells, usually occurs within 15-30 minutes of exposure.
Mechanism: Antibodies bind to specific tissue antigens marking cells for destruction, mediated by complement system and phagocytosis.
Symptoms vary based on the affected tissue.
Examples of Type II Reactions:
ABO transfusion reactions.
Hemolytic disease of the newborn.
Hyperacute graft rejection.
Graves' disease.
Myasthenia gravis.
Type 1 diabetes mellitus.
Type III Hypersensitivity
Mechanism: Antibody-antigen complexes deposit in tissues and activate the complement system causing inflammation and destruction.
Etiology: Occurs when immune and phagocytic systems fail to effectively clear these complexes.
Conditions: Chronic infection that persists as a source of circulating antigens.
Examples:
Serum sickness.
Immune complex glomerulonephritis.
Arthus reaction.
Type IV Hypersensitivity
Description: T-cell mediated (no antibody production) resulting in delayed hypersensitivity.
Timeframe: Reacts slowly (~24 hours) and may last for 14 days.
Mechanism: T-cells react with altered or foreign cells, leading to inflammation.
Principal effector cells: Lymphocytes and macrophages.
Examples:
Tuberculin skin test, contact dermatitis (poison ivy), transplant rejection.
Immune Deficiencies
Types of Immune Deficiencies
Primary Immunodeficiencies (PID):
Congenital; genetic defects leading to functional deficiencies.
Clinical hallmark: Tendency to develop unusual or recurrent severe infections.
Secondary Immunodeficiencies:
More common; induced by conditions such as cancer, stress, malnutrition, or acquired immunodeficiency (e.g., HIV/AIDS).
Primary Immunodeficiency Disorders
Definition: Congenital immune deficiencies caused by genetic defects affecting immunity.
Common types:
B cell deficiencies.
T cell deficiencies.
Combined T and B cell deficiencies.
Phagocyte deficiencies.
Complement deficiencies.
Untreated, can lead to frequent and life-threatening infections.
Examples of Primary Immunodeficiencies
X-Linked Agammaglobulinemia (Bruton's Disease).
Severe Combined Immunodeficiency (SCID): Lack of both B and T lymphocyte function, severe infection susceptibility.
Selective IgA Deficiency (fairly common).
Acquired Immunodeficiency Syndrome (AIDS)
Definition: Secondary immune deficiency caused by the human immunodeficiency virus (HIV).
Characteristics:
Blood borne RNA virus present in body fluids.
Transmission routes: Blood products, IV drug use, sexual activity, maternal-child.
HIV infects and depletes T helper cells (CD4+), increasing susceptibility to infections and malignancies.
Statistics:
Worldwide incidence (2013): 35.3 million individuals.
United States incidence (2012): approximately 49,000 individuals.
Pathogenesis of HIV/AIDS
Definition: Retrovirus with RNA genetic material.
Mechanism: Uses reverse transcriptase to convert RNA into double-stranded DNA, thus integrating with the host genome.
Human Immunodeficiency Virus (HIV) Structure and Function
Structure: gp120 protein binds to CD4 on helper T cells leading to their destruction.
Normal CD4+ count ranges from to cells/mm³.
HIV typically reverses CD4/CD8 ratio.
Clinical Manifestations of HIV/AIDS
Stage Definitions:
Serologically negative: no antibodies.
Serologically positive but asymptomatic: presence of antibodies but no symptoms.
AIDS stage: defined when CD4+ cells fall below cells/mm³ and benchmark clinical conditions arise.
AIDS-defining conditions: include opportunistic infections such as.
Pneumocystis jiroveci pneumonia (PCP).
Mycobacterium avium complex (MAC).
Mycobacterium tuberculosis.
Cytomegalovirus (CMV).
Kaposi's sarcoma.
Candidiasis in respiratory areas.
CD4+ Cell Count and Associated Risks
Above CD4+ cells/mm³: Low infection risk; promote good health practices.
CD4+ cells/mm³: Risk for shingles, thrush, and minor opportunistic infections.
CD4+ cells/mm³: Increased risk for serious opportunistic infections; preventative treatment indicated.
Below CD4+ cells/mm³: High risk for severe opportunistic infections; continued preventative medications recommended.
Treatment of HIV/AIDS
Treatment involves taking antiviral medications to slow HIV progression.
Antiretroviral Therapy (ART): Combination of three or more drugs offered to optimize treatment outcomes.
Components include:
Reverse transcriptase inhibitors.
Protease inhibitors.
Integrase inhibitors.
Fusion inhibitors.
CCR5 antagonists.
Not a cure, but significantly lowers mortality rates.
Worksheet
Immunologic Dysfunction Worksheet
1. Describe what is meant by a hypersensitivity reaction.
A hypersensitivity reaction is when the immune system overreacts to something harmless or misidentifies the body’s own cells as harmful, causing tissue damage and disease instead of protection.
🧬 Detailed Pathophysiology Breakdown
What It Means
Normally, the immune system protects us by recognizing and destroying harmful invaders (like bacteria, viruses, or toxins).
In hypersensitivity, the immune system responds inappropriately — either too strongly or against the wrong target.
This exaggerated response leads to collateral damage: inflammation, cell destruction, or dysfunction of normal tissues.
Why It Happens
Sensitization phase
On first exposure to an antigen (like pollen, food, or even self-antigens), the immune system “remembers” it.
Antibodies (IgE, IgG, IgM) or T cells are primed to react the next time.
Re-exposure phase
When the antigen reappears, the immune system launches a stronger, faster attack.
Instead of helping, this attack damages normal tissues.
Types (Gell & Coombs Classification)
Type I (IgE-mediated): Allergies, asthma, anaphylaxis. Mast cells release histamine → swelling, itching, bronchospasm.
** on slide: basophils also stimulated; Mast cells are connective tissue and basophils are in the blood.
Type II (Cytotoxic): Antibodies attack specific cells (e.g., mismatched blood transfusion, Graves disease).
She mentioned: remember GRAVES disease, and that Type 2 leads to destruction of cell or altered function of the cell.
Type III (Immune complex): Antigen-antibody complexes deposit in tissues → inflammation (e.g., lupus, glomerulonephritis).
Type IV (T-cell mediated): Delayed reaction, no antibodies. T cells cause tissue damage (e.g., TB skin test, poison ivy).
Clinical Significance
Hypersensitivity explains allergies, autoimmune diseases, and transplant rejection.
The key problem is immune misidentification: the body thinks harmless antigens or its own cells are dangerous.
Symptoms range from mild (rash, sneezing) to severe (anaphylaxis, organ damage).
✨ Easy Analogy
Think of the immune system as a security guard:
Normally, it attacks intruders.
In hypersensitivity, the guard panics and attacks friendly visitors or even the building itself, causing damage.
✅ Key Point for Exams: Hypersensitivity = exaggerated or misdirected immune response → tissue injury and disease.
2. Describe the 4 types of hypersensitivity reactions and give an example of each one.
🧬 Four Types of Hypersensitivity Reactions
Type | Mechanism of Immune Reaction (Why it happens) | Example of Reaction |
Type I (Immediate / IgE-mediated) | IgE antibodies bind to mast cells → re-exposure to allergen cross-links IgE → mast cells release histamine, leukotrienes, prostaglandins → vasodilation, bronchoconstriction, inflammation. | Allergic asthma, hay fever, bee sting allergy, anaphylaxis |
Type II (Cytotoxic / Tissue-specific) | IgG or IgM antibodies bind to antigens on specific cells → complement activation or phagocytosis destroys those cells. Damage is targeted to one tissue. | ABO blood transfusion reaction, Hemolytic disease of the newborn, Graves disease, Myasthenia gravis |
Type III (Immune complex-mediated) | Antigen-antibody complexes form in circulation → deposit in tissues → activate complement → attract neutrophils → inflammation and tissue damage. Not tissue-specific, depends on where complexes lodge. | Systemic lupus erythematosus (SLE), post-strep glomerulonephritis, serum sickness, Arthus reaction |
Type IV (Delayed / T-cell mediated) | Sensitized T lymphocytes (CD4+ helper and CD8+ cytotoxic) react directly to antigen → release cytokines → recruit macrophages → tissue damage. No antibodies involved. Reaction peaks 48–72 hrs. | Tuberculin skin test (PPD), poison ivy contact dermatitis, transplant rejection |
✨ Easy Memory Hook
Type I = Immediate (IgE, Allergies)
Type II = “It’s on the cell” (antibody attacks tissue)
Type III = “Immune Complexes clog” (deposit in tissues)
Type IV = “Delayed T-cell” (cell-mediated, no antibodies)
✅ Exam Key Point: Types I–III are antibody-mediated, Type IV is T-cell mediated.
3. What is a clinical sign that an individual has a primary immunodeficiency? Which cells are affected when a person has a primary immunodeficiency?
🧬 Primary Immunodeficiency
Clinical Sign
· The hallmark sign is recurrent, unusual, or severe infections that don’t respond normally to treatment.
· These infections often begin in early childhood (before age 2) and may involve unusual organisms or repeated infections in the same sites (ears, sinuses, lungs, skin).
· Example: a child with repeated pneumonia, ear infections, or thrush despite antibiotics.
Why? Because the immune system is missing or defective from birth (genetic defect), the body cannot mount normal defenses → infections keep coming back.
Cells Affected
Primary immunodeficiencies can involve any major immune cell type, depending on the genetic defect:
· B cells (humoral immunity) → ↓ antibodies → recurrent bacterial infections (e.g., X-linked agammaglobulinemia).
· T cells (cell-mediated immunity) → ↓ cytotoxic/helper function → viral, fungal, opportunistic infections.
· Combined T & B cell defects → severe combined immunodeficiency (SCID, “boy-in-the-bubble”).
· Phagocytes → impaired ability to engulf/kill pathogens → chronic bacterial infections.
· Complement proteins → defective opsonization/lysis → recurrent Neisseria infections.
Why? Each immune cell type has a specialized role. If one is missing, the “defense team” is incomplete → pathogens slip through.
✨ Key Exam Point
· Clinical sign: recurrent, severe, or unusual infections (especially in young children).
· Cells affected: can be B cells, T cells, both, phagocytes, or complement proteins, depending on the genetic defect.
4. What can cause secondary immunodeficiency?
🧬 Secondary (Acquired) Immunodeficiency
Definition
· Unlike primary immunodeficiency (genetic, present from birth), secondary immunodeficiency develops later in life due to external factors that weaken the immune system.
· It is much more common than primary forms.
Causes (and the “Why”)
1. Infections
o Example: HIV/AIDS → virus destroys CD4+ T helper cells.
o Why? Loss of T cells cripples both humoral and cell-mediated immunity.
2. Cancer
o Leukemia, lymphoma, or bone marrow cancers.
o Why? Malignant cells crowd out normal immune cells → reduced production/function.
3. Medications/Drugs
o Chemotherapy, radiation, immunosuppressants, corticosteroids.
o Why? These treatments kill rapidly dividing cells, including immune cells, or suppress immune activity.
4. Poor Nutrition/Malnutrition
o Protein-calorie malnutrition, vitamin/mineral deficiencies (zinc, iron).
o Why? Nutrients are required for lymphocyte development and antibody production.
5. Stress/Neuroendocrine factors
o Chronic stress → ↑ cortisol.
o Why? Cortisol suppresses lymphocyte activity and inflammation.
6. Normal Physiologic Changes
o Aging → gradual decline in immune function (“immunosenescence”).
o Why? Bone marrow and thymus activity decrease, fewer naïve T cells produced.
✨ Key Exam Point
· Secondary immunodeficiency = acquired later in life due to infection, disease, drugs, nutrition, stress, or aging.
· Why? These factors either destroy immune cells, suppress their function, or prevent their production.
5. Describe how the human immunodeficiency virus (HIV) is transmitted. How does HIV cause disease?
🧬 Transmission of HIV
HIV is a blood-borne RNA virus found in body fluids. It is transmitted when infected fluids come into direct contact with mucous membranes or the bloodstream.
Main routes:
· Sexual contact (heterosexual or homosexual) → virus enters through genital/rectal mucosa.
· Blood exposure → transfusions (rare now), needle sharing, IV drug use.
· Mother-to-child → during pregnancy, birth, or breastfeeding.
· Healthcare exposure → accidental needle sticks.
Why? HIV is fragile outside the body but survives in blood and certain fluids. Transmission requires direct fluid-to-blood/mucosa contact.
🧬 How HIV Causes Disease
1. Entry into cells
o HIV has a surface protein (gp120) that binds specifically to CD4 receptors on T helper cells.
o It also needs co-receptors (CCR5 or CXCR4) to enter.
o On slide she mentioned on EXAM: Structure – gp120 protein binds to the CD4 molecule found primarily on surface of helper Tcells
1. Destroys CD4 + Th cells.
2. Replication
o HIV is a retrovirus → it carries RNA and uses reverse transcriptase to convert RNA → DNA.
o Viral DNA integrates into host genome → host cell becomes a “virus factory.”
3. Destruction of CD4+ T cells
o Infected T helper cells are destroyed directly or undergo apoptosis.
o Over time, CD4 count drops (normal ~800–1000 cells/mm³ → AIDS <200 cells/mm³).
4. Immune system collapse
o Without T helper cells, both cell-mediated immunity (T cells) and humoral immunity (B cells/antibodies)fail.
o Body becomes vulnerable to opportunistic infections (PCP pneumonia, CMV, TB, candidiasis) and cancers (Kaposi’s sarcoma, lymphoma).
Why? HIV targets the “commanders” of the immune system (CD4+ T cells). When commanders are gone, the rest of the immune army cannot coordinate defense → infections and malignancies take over.
✨ Key Exam Points
· Transmission: blood, sexual contact, mother-to-child, needle exposure.
· Pathophysiology: HIV binds CD4 → enters cells → reverse transcriptase → integrates DNA → destroys T helper cells → immune collapse.
· Result: Opportunistic infections and cancers define AIDS.
6. What is the criteria for assigning a diagnosis of AIDS? List some of the “AIDS-defining conditions”.
🧬 Criteria for AIDS Diagnosis
A person is diagnosed with AIDS (Acquired Immunodeficiency Syndrome) when:
1. CD4+ T helper cell count < 200 cells/mm³ (normal is ~800–1000).
o Why? HIV destroys CD4+ cells, which are the “commanders” of the immune system. Below 200, the immune system can no longer coordinate defense.
2. Presence of AIDS-defining conditions (opportunistic infections or cancers).
o Why? These infections/cancers only occur when the immune system is severely weakened.
3. Positive HIV test (antibodies or viral RNA detected).
🧬 AIDS-Defining Conditions
These are illnesses that signal the immune system is critically compromised:
· Opportunistic infections
o Pneumocystis jiroveci pneumonia (PCP)
o Mycobacterium avium complex (MAC)
o Mycobacterium tuberculosis (TB)
o Cytomegalovirus (CMV) infection
o Candidiasis (esophagus, bronchi, trachea, lungs)
· Cancers
o Kaposi’s sarcoma (vascular tumor linked to HHV-8)
o Non-Hodgkin lymphoma
o Invasive cervical cancer
· Other severe conditions
o Wasting syndrome (unexplained weight loss >10% with diarrhea/weakness/fever)
o Recurrent bacterial infections
✨ Key Exam Point
· Diagnosis of AIDS = HIV infection + CD4 <200 + AIDS-defining condition.
· Why? At this stage, the immune system is so damaged that infections and cancers normally controlled by immunity can now take hold.
On slide in Red: CD4 (T helper) cells need to be <200 cells/mm3 AND they have to have various clinical conditions and lab results.
7. Drugs used to treat HIV infection target different aspects of how a virus infects a cell and replicates. Name the type of drugs used in Antiretroviral therapy (ART).
🧬 Antiretroviral Therapy (ART) Drug Classes
Drug Class | Mechanism (Why it helps) | Example Drugs |
Reverse Transcriptase Inhibitors (RTIs) | HIV is a retrovirus → it must convert its RNA into DNA using reverse transcriptase. RTIs block this enzyme, stopping viral DNA formation. | Zidovudine (AZT), Lamivudine, Tenofovir |
Protease Inhibitors (PIs) | HIV makes long protein chains that must be cut by protease into functional viral proteins. PIs block protease → virus particles remain immature and noninfectious. | Ritonavir, Indinavir |
Integrase Inhibitors | HIV DNA must be inserted into host cell DNA by integrase. These drugs block integrase → viral DNA cannot integrate → infection stalls. | Raltegravir, Dolutegravir |
Fusion Inhibitors | HIV must fuse with the host cell membrane to enter. Fusion inhibitors block this step → virus cannot get inside. | Enfuvirtide |
CCR5 Antagonists (Entry Inhibitors) | HIV uses co-receptor CCR5 to enter CD4+ cells. These drugs block CCR5 → virus cannot attach/enter. | Maraviroc |
✨ Key Exam Point
· ART = combination therapy (usually 3+ drugs from different classes).
· Why? HIV mutates quickly. Using multiple drug classes prevents resistance and attacks the virus at multiple stages: entry → reverse transcription → integration → protein processing.
✅ Summary for your study guide: ART drugs include reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors, fusion inhibitors, and CCR5 antagonists. Each targets a different step in HIV’s life cycle to stop replication.